Squarepoint’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.47M | Sell |
30,278
-42,746
| -59% | -$2.08M | ﹤0.01% | 1306 |
|
|
2025
Q1 | $2.49M | Sell |
73,024
-93,115
| -56% | -$3.17M | ﹤0.01% | 1058 |
|
|
2024
Q4 | $6.54M | Sell |
166,139
-82,840
| -33% | -$3.26M | 0.01% | 665 |
|
|
2024
Q3 | $11.7M | Sell |
248,979
-19,844
| -7% | -$932K | 0.02% | 457 |
|
|
2024
Q2 | $14.5M | Sell |
268,823
-5,207
| -2% | -$281K | 0.02% | 367 |
|
|
2024
Q1 | $18.7M | Buy |
274,030
+146,672
| +115% | +$10M | 0.03% | 311 |
|
|
2023
Q4 | $7.97M | Sell |
127,358
-17,719
| -12% | -$1.11M | 0.02% | 519 |
|
|
2023
Q3 | $6.59M | Buy |
145,077
+17,665
| +14% | +$802K | 0.02% | 515 |
|
|
2023
Q2 | $7.15M | Sell |
127,412
-3,506
| -3% | -$197K | 0.02% | 463 |
|
|
2023
Q1 | $5.92M | Sell |
130,918
-35,516
| -21% | -$1.61M | 0.02% | 467 |
|
|
2022
Q4 | $6.77M | Buy |
166,434
+96,783
| +139% | +$3.93M | 0.03% | 394 |
|
|
2022
Q3 | $4.55M | Buy |
+69,651
| New | +$4.55M | 0.02% | 489 |
|
|
2021
Q3 | – | Sell |
-5,400
| Closed | -$874K | – | 2318 |
|
|
2021
Q2 | $874K | Sell |
5,400
-6,452
| -54% | -$1.04M | ﹤0.01% | 1271 |
|
|
2021
Q1 | $1.44M | Buy |
11,852
+6,797
| +134% | +$828K | 0.01% | 880 |
|
|
2020
Q4 | $774K | Buy |
+5,055
| New | +$774K | 0.01% | 1216 |
|
|
2020
Q2 | – | Sell |
-13,533
| Closed | -$574K | – | 2194 |
|
|
2020
Q1 | $574K | Sell |
13,533
-43,352
| -76% | -$1.84M | 0.01% | 963 |
|
|
2019
Q4 | $3.47M | Buy |
+56,885
| New | +$3.47M | 0.02% | 613 |
|
|
2019
Q3 | – | Sell |
-6,348
| Closed | -$299K | – | 2280 |
|
|
2019
Q2 | $299K | Buy |
6,348
+494
| +8% | +$23.3K | ﹤0.01% | 1880 |
|
|
2019
Q1 | $209K | Sell |
5,854
-14,496
| -71% | -$518K | ﹤0.01% | 1879 |
|
|
2018
Q4 | $581K | Buy |
+20,350
| New | +$581K | 0.01% | 1156 |
|
|
2018
Q2 | – | Sell |
-7,919
| Closed | -$362K | – | 1785 |
|
|
2018
Q1 | $362K | Buy |
+7,919
| New | +$362K | 0.01% | 1219 |
|